Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Cochlear Implanted Listening Effort and Hearing Attention

NCT04733950 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2021-12-08
Last updated
2025-01-13

Condition(s) studied

Sensorineural Hearing Loss

Investigational drug(s) / intervention(s)

Forced choice psychoacoustic task for the evaluation of modulation detection performance and selective auditory attention. (for both arm)Measurement of the pupil diameter for the evaluation of listening effort during speech perception

Forced choice psychoacoustic task for the evaluation of modulation detection performance and selective auditory attention. (for both arm): Description: 3-interval, 3-alternative forced choice amplitude modulation detection task using a target sinusoidal carrier and a spectrally distant, interfering (distracting), sinusoidal carrier that may or not be modulated at the same rate as the target.

Measurement of the pupil diameter for the evaluation of listening effort during speech perception: Pupil diameter is recorded using an eye-tracker device (Tobii Pro TX300) while the subject performs a 16-alternative consonant identification task both in silence and in the presence of interfering speech.

Study summary

Cochlear implant users perceive mainly sound amplitude modulation cues. Processing of these amplitude modulations can be subject to interferences, so that the perception of a modulation in a target sound can be impaired by a superimposed sound if this sound contains a similar modulation. Such phenomenon, which is observed both in subjects with normal-hearing and in cochlear-implant users, could be explained by difficulties to direct attention to relevant information in complex sound signals. Selective auditory attention also plays a crucial role in speech comprehension in cocktail-party situations where the speech of multiple talkers get mixed at the ear of a listener. Cochlear implant users typically struggle in these cocktail-party situations and report intense listening effort.

The present clinical trial aims at evaluating the contribution of selective auditory attention for sound modulations to the listening effort of patients with cochlear implants and of healthy volunteers with normal-hearing during speech perception under cocktail-party-like conditions.

Selective auditory attention abilities of patients and controls will be assessed using a psychoacoustical test whereby their ability to detect a target sound amplitude modulation will be measured both in the absence and in the presence of an interfering (i.e. distracting) amplitude modulation occurring in a distant spectral region from that of the target. The effect of this distractor's presence on modulation detection performance will serve as a behavioural index of the subject's auditory attention capacities.

The attentional capacity index will then be tested as a predicting factor for the listening effort of the subject during a speech-in-noise consonant identification task. Listening effort will be measured from the pupil dilation response to the presented speech units (pseudowords).

This study will enhance our understanding of cochlear implant user's perception and listening effort and will serve as a basis for prognostic tests of listening effort and of implantation success for cochlear implant candidates, based on a simple measurement of auditory attentional abilities.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: Arm 1: patient with Cochlear Implant * Having a unilateral Oticon Medical cochlear implant * Duration of use of the implant of 6 months or more * Disyllabic word recognition score of at least 40% on average in silence, to limit "floor" effects in hearing tests. * Disyllabic word recognition score not exceeding 30% on the contra-lateral ear alone, aided or not, in silence. Arm 2: volunteers with normal hearing \- Normal tonal audiometry for the age For both * Age between 18 and 80 years old * Mother tongue : French * Normal vision with or without correction * Absence of eye pathologies (cataracts, nystagmus, amblyopia, macular degeneration). * Not taking psychotropic drugs or drugs affecting the parasympathetic nervous system * Absence of pathology or neurological history (especially head trauma, stroke). * Information and signing of a consent prior to any act related to research Exclusion Criteria: For both groups, ensuring the reliability of the pupillometric measurement (Winn et al., 2018): * Pathologies of the eye: cataracts, nystagmus, amblyopia, macular degeneration. * Taking psychotropic drugs and / or drugs affecting the parasympathetic nervous system * Neurological pathology (in particular head trauma or stroke) associated with an alteration of cognitive functions or history thereof that may affect the stability of the gaze, the congruence of eye movements, pupillary dilation or with an alteration of cognitive functions Others criteria: * No affiliation (or being entitled) to a social security scheme * Person under State Medical Assistance * Person under legal protection (tutorship, curatorship, other…) or under family authorization

Primary outcome measure(s)

  • Contribution of selective auditory attention recruitment to listening effort during speech perception in interfering noise — at study inclusions completion, 18 months after firsth enrollment
    Statistical correlation between * the effect of a distractor on the performance of patients in a sound modulation detection task, and * the effect of introducing interfering noise on an objective measure of the listening effort of these same patients (pupillary response) while performing a speech identification task

Trial sites (1)

FacilityCityRegionStatus
Assistance Publique-Hôpitaux de Paris Paris France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04733950 on ClinicalTrials.gov ↗ ← All trials in France